Key elements of the Biotechnology Industry
Organization's legislative proposal to improve capital formation.
|
•
|
Expand
eligibility for preferential capital gains treatment under Section 1202 of
the Internal Revenue Code to include businesses with up to $150M in gross
assets (from $50M)
|